Disclaimer for Respondents

Your participation in this study is completely voluntary. The questionnaire is designed only for research purposes to understand medically supervised, allopathy-based weight management centres and programs. You may choose not to answer specific questions or withdraw at any time without any consequence.

All information you provide will be kept confidential and used only in aggregated form for analysis. No individual centre or respondent will be identified in reporting without prior consent.

By continuing, you confirm that you are willing to participate and understand that your input will be used solely for study purposes.

Screener Section (Eligibility & Branch Status)
S1. Is your centre currently operational for medically supervised, allopathy-based weight-management services?
Screener Section (Eligibility & Branch Status)
S2. Please confirm your centre type and location.
Screener Section (Eligibility & Branch Status)
S3. How many branches does your organisation operate for weight-management services?
Screener Section (Eligibility & Branch Status)
S4. If some branches are under process, please indicate their status.
SECTION A — Market Presence & Centre Type
Q1. What is the current scope of medically supervised, allopathy-based weight-management services offered at your centre?
SECTION A — Market Presence & Centre Type
Q2. Which category best describes your centre?
SECTION A — Market Presence & Centre Type
Q3. How long has your centre been offering weight-management services?
SECTION A — Market Presence & Centre Type
Q4. What is your average daily footfall of medically supervised weight-management patients?
Section B — Medical Governance & Services
Q5. Which medical specialists are directly involved in your weight-management programs?
Section B — Medical Governance & Services
Q6. Are all weight-management services delivered under physician supervision (MBBS/MD or equivalent)?
Section B — Medical Governance & Services
Q7. Which of the following medically supervised services are offered at your centre?
SECTION C — GLP 1 / Medicine-driven Weight Management
Q8. Does your centre currently prescribe GLP 1 or other anti obesity medicines under physician supervision?
SECTION C — GLP 1 / Medicine-driven Weight Management
Q9. What proportion of your weight management patients are currently on GLP 1 / medicines?
SECTION C — GLP 1 / Medicine-driven Weight Management
Q10. Which GLP 1 medication you primarily offer?
SECTION C — GLP 1 / Medicine-driven Weight Management
Q11. What is the typical duration of GLP 1 / medicine based programs (structured packages only)?
SECTION C — GLP 1 / Medicine-driven Weight Management
Q12. Please describe any additional protocols or monitoring practices followed for GLP 1 patients (e.g., lab tests, cardio metabolic screening, adherence checks).
SECTION D — Patient Demand & Preferences
Q13. Which approach do patients most commonly prefer at your centre?
SECTION D — Patient Demand & Preferences
Q14. What concerns do patients most commonly express about GLP 1 therapy?
SECTION D — Patient Demand & Preferences
Q15. Please describe any additional patient feedback, expectations, or unmet needs regarding GLP 1 or other medicine-based programs.
SECTION E — Market Growth, Economics & Investment Outlook
Q16. Over the last 12 months, demand for medically supervised eight management services at your centre has:
SECTION E — Market Growth, Economics & Investment Outlook
Q17. In your opinion, is investment in medicine based (GLP 1) weight management worth pursuing for long term growth?
SECTION F — Risks, Barriers & Decision Signals
Q18. What are the biggest risks to growth in medically supervised weight management services?
SECTION F — Risks, Barriers & Decision Signals
Q19. Does your centre systematically track and document patient outcomes?
SECTION G — Pharma Investment Outlook & Strategic Decisions
Q20. What is your current model, have you partnered/tie up with any company (for supply of GLP-1 therapy)?
SECTION G — Pharma Investment Outlook & Strategic Decisions
Q21. Would you like to partner/tie-up with any company (for supply of GLP-1 therapy)?

Survey Completed

Thank you for your participation.